v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (27,042) $ (11,276)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 2,765 2,123
Depreciation and amortization 1,318 1,140
Amortization of deferred costs 1,070 1,585
Non-cash operating lease expense 811 417
Changes in operating assets and liabilities:    
Accounts receivable (1,201) (520)
Inventories 13 (3)
Deferred costs (1,692) (1,512)
Prepaid expenses and other current assets 101 (2,206)
Other assets (9) 0
Accounts payable 1,226 2,275
Accrued and other current liabilities 2,308 425
Deferred revenue 306 (282)
Operating lease liabilities (727) (350)
Net cash used in operating activities (20,753) (8,184)
Cash flows from investing activities:    
Purchase of property, plant and equipment (11,799) (747)
Net cash used in investing activities (11,799) (747)
Cash flows from financing activities:    
Proceeds from issuance of common stock in connection with a stock purchase agreement 16,542 0
Payments of financing costs (406) (25)
Proceeds from exercise of stock options 115 8
Proceeds from exercise of stock warrants 1 0
Proceeds from issuance of common stock in connection with Business Combination and PIPE investment 0 77,884
Payment of transaction and issuance costs in connection with Business Combination and PIPE investment 0 (6,794)
Capital contributions from Amprius Holdings 0 505
Net cash provided by financing activities 16,252 71,578
Net (decrease) increase in cash, cash equivalents and restricted cash (16,300) 62,647
Cash, cash equivalents and restricted cash, beginning of period 69,752 11,489
Cash, cash equivalents and restricted cash, end of period 53,452 74,136
Reconciliation of cash, cash equivalents and restricted cash shown on the condensed consolidated balance sheets:    
Cash and cash equivalents 53,396 73,803
Restricted cash included in other assets 56 333
Total cash, cash equivalents and restricted cash $ 53,452 $ 74,136

Source